课题基金 / 基金详情

Improving treatment efficacy: A randomized controlled trial of the combined used of intranasal oxytocin and cognitive behavioral therapy for the treatment of major depressive disorder

Improving treatment efficacy: A randomized controlled trial of the combined used of intranasal oxytocin and cognitive behavioral therapy for the treatment of major depressive disorder
提高治疗效果：鼻内催产素联合认知行为疗法治疗重度抑郁症的随机对照试验
批准号：
358659
负责人：
Ellenbogen Mark A
金额：
$50.71万
依托单位：
Concordia University (Montreal, Quebec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-10-01 至 2021-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=358659&lang=en
关键词：
Cognitive-Behavioural Therapy Epigenetics Eye Tracking Information Processing Intranasal Oxytocin Major Depressive Disorder Psychotherapy Randomized Controlled Trial

项目摘要

项目成果

Ellenbogen Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Major depressive disorder (MD) is recurrent, debilitating, and, to some extent, a chronic disorder, despite the many advances in treatment. Although both drug and psychological treatments are considered to be efficacious in the short-term treatment of MD,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The social information processing response to intranasal oxytocin as a potential marker of social vulnerability and risk for depression
The social information processing response to intranasal oxytocin as a potential marker of social vulnerability and risk for depression
海外基金